These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 29192863

  • 1. Precipitating hydrophobic injectable liquid embolization of intracranial vascular shunts: initial experience and technical note.
    Varadharajan S, Ramalingaiah AH, Saini J, Gupta AK, Devi BI, Acharya UV.
    J Neurosurg; 2018 Nov 01; 129(5):1217-1222. PubMed ID: 29192863
    [Abstract] [Full Text] [Related]

  • 2. Preliminary experience with the liquid embolic material agent PHIL (Precipitating Hydrophobic Injectable Liquid) in treating cranial and spinal dural arteriovenous fistulas: technical note.
    Leyon JJ, Chavda S, Thomas A, Lamin S.
    J Neurointerv Surg; 2016 Jun 01; 8(6):596-602. PubMed ID: 25994938
    [Abstract] [Full Text] [Related]

  • 3. Initial experience with precipitating hydrophobic injectable liquid in cerebral arteriovenous malformations.
    Sirakov SS, Sirakov A, Minkin K, Hristov H, Ninov K, Penkov M, Karakostov V, Orlov K, Gorbatykh A, Kislitsin D, Raychev R.
    Interv Neuroradiol; 2019 Feb 01; 25(1):58-65. PubMed ID: 30223686
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of a novel liquid embolic agent (precipitating hydrophobic injectable liquid (PHIL)) in an animal endovascular embolization model.
    Vollherbst DF, Otto R, von Deimling A, Pfaff J, Ulfert C, Kauczor HU, Bendszus M, Sommer CM, Möhlenbruch MA.
    J Neurointerv Surg; 2018 Mar 01; 10(3):268-274. PubMed ID: 28689184
    [Abstract] [Full Text] [Related]

  • 5. Transvenous embolization of brain arteriovenous malformations: a review of techniques, indications, and outcomes.
    Chen CJ, Norat P, Ding D, Mendes GAC, Tvrdik P, Park MS, Kalani MY.
    Neurosurg Focus; 2018 Jul 01; 45(1):E13. PubMed ID: 29961383
    [Abstract] [Full Text] [Related]

  • 6. Glue, Onyx, Squid or PHIL? Liquid Embolic Agents for the Embolization of Cerebral Arteriovenous Malformations and Dural Arteriovenous Fistulas.
    Vollherbst DF, Chapot R, Bendszus M, Möhlenbruch MA.
    Clin Neuroradiol; 2022 Mar 01; 32(1):25-38. PubMed ID: 34324005
    [Abstract] [Full Text] [Related]

  • 7. ONYX versus n-BCA for embolization of cranial dural arteriovenous fistulas.
    Rabinov JD, Yoo AJ, Ogilvy CS, Carter BS, Hirsch JA.
    J Neurointerv Surg; 2013 Jul 01; 5(4):306-10. PubMed ID: 22550096
    [Abstract] [Full Text] [Related]

  • 8. Novel use of precipitating hydrophobic injectable liquid (PHIL) in pre-operative angioembolisation of a large posterior auricular arteriovenous malformation.
    Chu C, Tan THL, Ng KS, Tan CS, Lee TS, Yuen HW, Lee W, Huang XY.
    Am J Otolaryngol; 2023 Jul 01; 44(2):103786. PubMed ID: 36680841
    [Abstract] [Full Text] [Related]

  • 9. Combined therapy of cerebral arteriovenous malformations: histological differences between a non-adhesive liquid embolic agent and n-butyl 2-cyanoacrylate (NBCA).
    Duffner F, Ritz R, Bornemann A, Freudenstein D, Wiendl H, Siekmann R.
    Clin Neuropathol; 2002 Jul 01; 21(1):13-7. PubMed ID: 11846039
    [Abstract] [Full Text] [Related]

  • 10. Liquid Embolic Agents for Endovascular Embolization: Evaluation of an Established (Onyx) and a Novel (PHIL) Embolic Agent in an In Vitro AVM Model.
    Vollherbst DF, Sommer CM, Ulfert C, Pfaff J, Bendszus M, Möhlenbruch MA.
    AJNR Am J Neuroradiol; 2017 Jul 01; 38(7):1377-1382. PubMed ID: 28522669
    [Abstract] [Full Text] [Related]

  • 11. The dual microcatheter technique for transvenous embolization of dural arteriovenous fistulae.
    Abecassis IJ, Nerva JD, Ghodke BV, Sekhar LN, Levitt MR, Kim LJ.
    J Neurointerv Surg; 2017 Jun 01; 9(6):578-582. PubMed ID: 27821474
    [Abstract] [Full Text] [Related]

  • 12. Preliminary experience with precipitating hydrophobic injectable liquid in brain arteriovenous malformations.
    Koçer N, Hanımoğlu H, Batur Ş, Kandemirli SG, Kızılkılıç O, Sanus Z, Öz B, Işlak C, Kaynar MY.
    Diagn Interv Radiol; 2016 Jun 01; 22(2):184-9. PubMed ID: 26782157
    [Abstract] [Full Text] [Related]

  • 13. Embolization of Intracranial Dural Arteriovenous Fistulas Using PHIL Liquid Embolic Agent in 26 Patients: A Multicenter Study.
    Lamin S, Chew HS, Chavda S, Thomas A, Piano M, Quilici L, Pero G, Holtmannspolter M, Cronqvist ME, Casasco A, Guimaraens L, Paul L, Gil Garcia A, Aleu A, Chapot R.
    AJNR Am J Neuroradiol; 2017 Jan 01; 38(1):127-131. PubMed ID: 27932510
    [Abstract] [Full Text] [Related]

  • 14. Staged transarterial endovascular embolization of a malignant dural arteriovenous fistula using Onyx and n-butyl cyanoacrylate.
    Gesheva S, Couldwell WT, Mortimer V, Taussky P, Grandhi R.
    Neurosurg Focus; 2019 Apr 01; 46(Suppl_2):V1. PubMed ID: 30939434
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Endovascular embolization for symptomatic perimedullary AVF and intramedullary AVM: a series and a literature review.
    Lv X, Li Y, Yang X, Jiang C, Wu Z.
    Neuroradiology; 2012 Apr 01; 54(4):349-59. PubMed ID: 21556862
    [Abstract] [Full Text] [Related]

  • 20. Evolution of treatment and a detailed analysis of occlusion, recurrence, and clinical outcomes in an endovascular library of 260 dural arteriovenous fistulas.
    Gross BA, Albuquerque FC, Moon K, McDougall CG.
    J Neurosurg; 2017 Jun 01; 126(6):1884-1893. PubMed ID: 27588586
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.